cover
Contact Name
Syafira Dwi Cahyani
Contact Email
adminjifi@univpancasila.ac.id
Phone
+6287780957284
Journal Mail Official
syafira.ffup@univpancasila.ac.id
Editorial Address
Editorial Office: Lenteng Agung St, Srengseng Sawah District, Jagakarsa Regency, Jakarta Selatan, Special Region of Jakarta 12640, Indonesia.
Location
Kota adm. jakarta selatan,
Dki jakarta
INDONESIA
Jurnal Ilmu Kefarmasian Indonesia
Published by Universitas Pancasila
ISSN : 16931831     EISSN : 26146495     DOI : -
Core Subject : Health, Science,
Jurnal Ilmu Kefarmasian Indonesia (JIFI) mainly focuses on a current topic in Pharmaceutical Sciences are also considered for publication by the Journal. Discussions on a topic in Pharmaceutical Sciences, Clinical Sciences, and Social Behaviour Administration. Detailed scopes of articles accepted for submission to JIFI are: 1. Pharmaceutical Biology 2. Pharmaceutical Chemistry. 3. Pharmaceutical Technology. 4. Biomedical and Clinical Pharmacy. 5. Social Pharmacy and Administration.
Articles 731 Documents
Comparative study of DOTS treatment outcomes among pulmonary tuberculosis patients at Bondongan and Bogor Timur primary health centers Khairani, Sondang; Reise Manninda; Lusiana Ariani; Sabina Radya Harumi
JURNAL ILMU KEFARMASIAN INDONESIA Vol. 24 No. 1 (2026): JIFI In Press
Publisher : Faculty of Pharmacy, Universitas Pancasila

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35814/jifi.v24i1.2105

Abstract

Tuberculosis (TB) remains a major infectious disease and a significant public health concern in Indonesia. The Directly Observed Treatment Short-course (DOTS) strategy has been widely implemented to improve treatment adherence and outcomes among patients with TB. This study aimed to compare the treatment outcomes of patients with pulmonary tuberculosis undergoing DOTS therapy at Bondongan Primary Health Center and Bogor Timur Primary Health Center. This study used a descriptive and inferential research design with retrospective data collection conducted in 2024. A total of 159 patients with pulmonary TB were included in the study. Data were analyzed based on patient characteristics, including age, sex, comorbidities, type of diagnosis, duration of treatment, and treatment outcomes. The results showed that the majority of patients at Bondongan Primary Health Center were aged 38–47 years (30.13%), whereas most patients at Bogor Timur Primary Health Center were aged 18–27 years (36.03%). Female patients accounted for 54.10% of the total population. Most patients received six months of treatment (84.91%), were bacteriologically confirmed (76.10%), and all patients received fixed-dose combination (FDC) therapy. At Bondongan Primary Health Center, the comorbidity status of diabetes mellitus (DM) was largely unknown (80.82%), whereas most patients at Bogor Timur Primary Health Center had no DM comorbidity (87.21%). The treatment success rates were 83.56% and 97.67% at the Bondongan and Bogor Timur Primary Health Centers, respectively. Statistical analysis indicated that patient characteristics were not significantly associated with treatment success (p≄0.05).